Successful ceftolozane/tazobactam treatment of chronic pulmonary infection with pan‐resistant Pseudomonas aeruginosa

Soliman, Reham, Lynch, Sarah, Meader, Emma, Pike, Rachel, Turton, Jane F., Hill, Robert L.R., Woodford, Neil and Livermore, David ORCID: https://orcid.org/0000-0002-9856-3703 (2015) Successful ceftolozane/tazobactam treatment of chronic pulmonary infection with pan‐resistant Pseudomonas aeruginosa. JMM Case Reports, 2. ISSN 2053-3721

Preview

PDF (jmmcr000025) - Published Version Available under License Creative Commons Attribution. Download (91kB) | Preview

Abstract

The treatment of chronic Pseudomonas aeruginosa infections is challenging, with resistance and antibiogram diversity accumulating during successive therapies. Some isolates are resistant to all licensed agents, creating treatment problems and an urgent need for new therapies. Among antibiotics in advanced development, ceftolozane/tazobactam has potent in vitro antipseudomonal activity, with low MICs even for strains with AmpC β‐lactamase‐, impermeability‐ and efflux‐mediated resistance to other β‐lactams.

Item Type:	Article
Additional Information:	This is an open access article published by the Society for General Microbiology under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/)
Uncontrolled Keywords:	pseudomonas,pan‐resistance, aeruginosa, ceftolozane‐tazobactam,bronchiectasis
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Science > School of Biological Sciences
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Depositing User:	Pure Connector
Date Deposited:	25 Aug 2015 09:24
Last Modified:	18 Oct 2022 16:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/54042
DOI:	10.1099/jmmcr.0.000025

Downloads

Actions (login required)

View Item